Sociodemographic factors responsible for blindness in diabetic Egyptian patients

Clinical Ophthalmology

Volumn 5, Issue 1, 2011, Pages 1593-1598

  Abueleinen, Khaled Gamal Ibraheem ^a   El Mekawey, Hany ^a   Saif, Yasser Sayed ^b   Khafagy, Amr ^a   Rizk, Hoda Ibrahim ^a   Eltahlawy, Eman M ^c  

^a CAIRO UNIVERSITY   (Egypt)

^b BENI SUEF UNIVERSITY   (Egypt)

^c NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Blindness; Education; Laser photocoagulation; Macular edema; Vitreous hemorrhage

Indexed keywords

ADULT; ARTICLE; BLINDNESS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DOCTOR PATIENT RELATION; EDUCATIONAL STATUS; EGYPT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS MEDIUM; MEDICAL INFORMATION; OBSERVATIONAL STUDY; PATIENT EDUCATION; RISK FACTOR; VISUAL IMPAIRMENT; VITREOUS HEMORRHAGE;

EID: 81055125639     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. World Health Organization (WHO). The World Health Report: conquering suffering, enriching humanity. Geneva: WHO; 1997.
2. Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes related complications. Phys Ther. 2008;88: 1254-1264.
3. Herman WH, Aubert RE, Engelgau MM, et al. Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications. Diabet Med. 1998;15:1045-1051.
4. Macky TA, Khater N, Al-Zamil MA, El Fishawy H, Soliman MM. Epidemiology of diabetic retinopathy in Egypt: a hospital-based study. Ophthalmic Res. 2011;45:73-78.
5. World Health Organization. Prevention of blindness and visual impairment Available from: http://www.who.int/blindness/causes/en/index.html Accessed July 5, 2011.
6. Coyne KS, Margolis MK, Kennedy-Martin T, et al. The impact of diabetic retinopathy: perspectives from patient focus groups. Fam Pract.2004;21:447-453.
7. American Academy of Ophthalmology. Preferred Practice Pattern: Diabetic Retinopathy. San Francisco: American Academy of Ophthalmology; 1993.
8. Klien R, Klien BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy II: prevalence and risk of diabetic retinopathy when age of diagnosis is less than 30 years. Arch Ophthalmol. 1984;103:520-526.
9. Klien R, Klien BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy IX: four year incidence and progression of diabetic retinopathy when age of diagnosis is less than 30 years. Arch Ophthalmol. 1989;107:237-243.
10. The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS report no 8. Ophthalmology.1981;88:583-600.
11. The Diabetic Retinopathy Study Research Group. Four risk factors for severe visual loss in diabetic retinopathy. The third report from the Diabetic Retinopathy Study. Arch Ophthalmol. 1979;97:654-655.
12. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmolol. 1985;103: 1796-1806.
13. Early treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report no, 9. Ophthalmology.1991;98:766-785.
14. Klein R, Klein BEK, Moss SE. The Wisconsin Epidemiological Study of Diabetic Retinopathy: a review. Diabetes Metab Rev. 1989;5(7): 559-570.
15. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabetic Med. 1997;14(Suppl 5):S1-S85.
16. Deepa M, Deepa R, Shanthirani CS, et al. Awareness and knowledge of diabetes in Chennai - the Chennai Urban Rural Epidemiology Study[CURES-9]. J Assoc Physicians India. 2005;53:283-287.
17. Department of Health (DOH). National Service Framework for Diabetes: standards. London: DOH; 2001.
18. Department of Health (DOH). National Service Framework for Diabetes: delivery strategy 29895. London: DOH; 2003.
19. National Institute for Clinical Excellence (NICE). Guidance on the Use of Patient-Education Models for Diabetes. Technology Appraisal 60. London: NICE; 2003.
20. Department of Health (DOH). The Performance and Planning Framework for 2003-2006. Improvement expansion and reform: the next three years. London: DOH; 2003.
21. Deakin TA, Cade JE, Williams R, Greenwood DC. Structured patient education: the Diabetes X-PERT Programme makes a difference. Diabetic Med. 2006;23(9):944-954.
22. Smith A. The economic impact of ophthalmic services for persons with diabetes in the Canadian province of Nova Scotia. Ophthalmic Epidemiol. 2001;8(1):13-25.